These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6974710)

  • 1. Use of Orthoclone monoclonal antibodies in the study of selected dermatologic conditions.
    Berger CL; Kung P; Goldstein G; DePietro W; Takezaki S; Chu A; Fithian E; Edelson RL
    Int J Immunopharmacol; 1981; 3(3):275-82. PubMed ID: 6974710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
    Faure M; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous T cell lymphoma: characterization by monoclonal antibodies.
    Kung PC; Berger CL; Goldstein G; LoGerfo P; Edelson RL
    Blood; 1981 Feb; 57(2):261-6. PubMed ID: 6160893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic use of monoclonal antibodies in a variety of dermatologic conditions.
    Berger CL; Chu A; Fithian E; Patterson J; Edelson RL
    Am J Dermatopathol; 1983 Feb; 5(1):85-94. PubMed ID: 6222665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of skin-infiltrating T cells in cutaneous T-cell lymphoma: comparison with benign cutaneous T-cell infiltrates.
    Haynes BF; Hensley LL; Jegasothy BV
    Blood; 1982 Aug; 60(2):463-73. PubMed ID: 7046848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
    Haynes BF; Metzgar RS; Minna JD; Bunn PA
    N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and lymph node T-lymphocyte subsets in non-Hodgkin lymphomas.
    Lindemalm C; Mellstedt H; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B; Sundblad R
    Scand J Haematol; 1983 Jan; 30(1):68-78. PubMed ID: 6601285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic modulation of pan-T-cell and T-cell subset-specific markers.
    Estabrook A; Mittler R; LoGerfo P; Hardy M; Edelson RL; Berger CL
    Diagn Immunol; 1983; 1(3):199-204. PubMed ID: 6209055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult T-cell leukemia/lymphoma with OKT4 lack of OKT8 in peripheral blood and with OKT4 and OKT8 in lymph node. Study of two color flow cytometry].
    Furukawa Y; Inoue T; Yamane T; Hiyoshi M; Sasaki A; Kishida T; Kojima K; Im T; Tatsumi N; Okuda K
    Rinsho Byori; 1989 Jul; 37(7):830-4. PubMed ID: 2532690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome.
    Fox RI; Carstens SA; Fong S; Robinson CA; Howell F; Vaughan JH
    Arthritis Rheum; 1982 Apr; 25(4):419-26. PubMed ID: 6978718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell population in the cutaneous infiltrate of mycosis fungoides: in situ using monoclonal antisera.
    Holden CA; Morgan EW; MacDonald DM
    Br J Dermatol; 1982 Apr; 106(4):385-92. PubMed ID: 6462163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies.
    Keystone EC; Lau C; Gladman DD; Wilkinson S; Lee P; Shore A
    Clin Exp Immunol; 1982 May; 48(2):443-8. PubMed ID: 6213329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification of human T-lymphocyte antigens defined by the OKT5 and OKT8 monoclonal antibodies.
    Phan-Dinh-Tuy F; Niaudet P; Bach JF
    Mol Immunol; 1982 Dec; 19(12):1649-54. PubMed ID: 6761583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface phenotype and in vitro function of adult T-cell leukemia cells.
    Uchiyama T; Hattori T; Wano Y; Tsudo M; Takatsuki K; Uchino H
    Diagn Immunol; 1983; 1(3):150-4. PubMed ID: 6094084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens.
    Platsoucas CD; Good RA
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4500-4. PubMed ID: 6974866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sub-populations of T helper suppressor lymphocytes in diverse dermatoses using monoclonal antibodies. Preliminary results (author's transl)].
    Fulton R; Thivolet J; Garcier F; Gaucherand M
    Ann Dermatol Venereol; 1981; 108(3):243-6, 249-50. PubMed ID: 6455084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OKT3 induces suppressor cells for mixed lymphocyte and PHA mitogenic responses in human peripheral lymphocytes.
    Lau C; Goldstein G
    Int J Immunopharmacol; 1981; 3(3):187-92. PubMed ID: 6457004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.